메뉴 건너뛰기




Volumn 2014, Issue , 2014, Pages

Pharmaceutical Options for Triggering of Final Oocyte Maturation in ART

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; KISSPEPTIN; GONADORELIN; LUTEINIZING HORMONE;

EID: 84935891258     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/580171     Document Type: Review
Times cited : (40)

References (53)
  • 1
    • 0018733914 scopus 로고
    • Structures of N-glycosidic carbohydrate units of human chorionic gonadotropin
    • M. J. Kessler, M. S. Reddy, R. H. Shah, and O. P. Bahl, "Structures of N-glycosidic carbohydrate units of human chorionic gonadotropin, "The Journal of Biological Chemistry, vol. 254, no. 16, pp. 7901-7908, 1979.
    • (1979) The Journal of Biological Chemistry , vol.254 , Issue.16 , pp. 7901-7908
    • Kessler, M.J.1    Reddy, M.S.2    Shah, R.H.3    Bahl, O.P.4
  • 5
    • 0028283353 scopus 로고
    • Suppression of the endogenous luteinizing hormone surge by the gonadotrophinreleasing hormone antagonist Cetrorelix during ovarian stimulation
    • K. Diedrich, C. Diedrich, E. Santos, et al., "Suppression of the endogenous luteinizing hormone surge by the gonadotrophinreleasing hormone antagonist Cetrorelix during ovarian stimulation, " Human Reproduction, vol. 9, no. 5, pp. 788-791, 1994.
    • (1994) Human Reproduction , vol.9 , Issue.5 , pp. 788-791
    • Diedrich, K.1    Diedrich, C.2    Santos, E.3
  • 6
    • 0342602067 scopus 로고    scopus 로고
    • Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation
    • C. Albano, H. Riethmuller-Winzen, J. Smitz, A. Van Steirteghem, M. Camus, and P. Devroey, "Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation, " Fertility and Sterility, vol. 67, no. 5, pp. 917-922, 1997.
    • (1997) Fertility and Sterility , vol.67 , Issue.5 , pp. 917-922
    • Albano, C.1    Riethmuller-Winzen, H.2    Smitz, J.3    Van Steirteghem, A.4    Camus, M.5    Devroey, P.6
  • 8
    • 0025883825 scopus 로고
    • Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist
    • J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J. M. Brandes, "Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist, " Fertility and Sterility, vol. 56, no. 2, pp. 213-220, 1991.
    • (1991) Fertility and Sterility , vol.56 , Issue.2 , pp. 213-220
    • Itskovitz, J.1    Boldes, R.2    Levron, J.3    Erlik, Y.4    Kahana, L.5    Brandes, J.M.6
  • 9
    • 0347356265 scopus 로고    scopus 로고
    • Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome
    • S. Kol, "Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome, " Fertility and Sterility, vol. 81, no. 1, pp. 1-5, 2004.
    • (2004) Fertility and Sterility , vol.81 , Issue.1 , pp. 1-5
    • Kol, S.1
  • 10
    • 79958694553 scopus 로고    scopus 로고
    • GnRH agonist for triggering of final oocyte maturation: Time for a change of practice?
    • P. Humaidan, S. Kol, and E. G. Papanikolaou, "GnRH agonist for triggering of final oocyte maturation: time for a change of practice?" Human Reproduction Update, vol. 17, no. 4, pp. 510-524, 2011.
    • (2011) Human Reproduction Update , vol.17 , Issue.4 , pp. 510-524
    • Humaidan, P.1    Kol, S.2    Papanikolaou, E.G.3
  • 11
    • 0029119040 scopus 로고
    • Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophinreleasing hormone antagonist-treatedmonkeys
    • M. B. Zelinski-Wooten, J. S. Hutchison, D. L. Hess, D. P. Wolf, and R. L. Stouffer, "Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophinreleasing hormone antagonist-treatedmonkeys, " Human Reproduction, vol. 10, no. 7, pp. 1658-1666, 1995.
    • (1995) Human Reproduction , vol.10 , Issue.7 , pp. 1658-1666
    • Zelinski-Wooten, M.B.1    Hutchison, J.S.2    Hess, D.L.3    Wolf, D.P.4    Stouffer, R.L.5
  • 12
    • 0018713280 scopus 로고
    • FSHstimulates hyaluronic acid synthesis by oocytecumulus cell complexes from mouse preovulatory follicles
    • J. J. Eppig, "FSHstimulates hyaluronic acid synthesis by oocytecumulus cell complexes from mouse preovulatory follicles, " Nature, vol. 281, no. 5731, pp. 483-484, 1979.
    • (1979) Nature , vol.281 , Issue.5731 , pp. 483-484
    • Eppig, J.J.1
  • 13
    • 20044373252 scopus 로고    scopus 로고
    • The potential role of gap junction communication between cumulus cells and bovine oocytes during in vitro maturation
    • A. Atef, P. Francois, V. Christian, and S. Marc-Andre, "The potential role of gap junction communication between cumulus cells and bovine oocytes during in vitro maturation, "Molecular Reproduction and Development, vol. 71, no. 3, pp. 358-367, 2005.
    • (2005) Molecular Reproduction and Development , vol.71 , Issue.3 , pp. 358-367
    • Atef, A.1    Francois, P.2    Christian, V.3    Marc-Andre, S.4
  • 14
    • 75749138165 scopus 로고    scopus 로고
    • 1, 500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: A prospective, randomized, controlled study
    • P. Humaidan, H. Ejdrup Bredkjar, L. G. Westergaard, and C. Yding Andersen, "1, 500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study, " Fertility and Sterility, vol. 93, no. 3, pp. 847-854, 2010.
    • (2010) Fertility and Sterility , vol.93 , Issue.3 , pp. 847-854
    • Humaidan, P.1    Ejdrup Bredkjar, H.2    Westergaard, L.G.3    Yding Andersen, C.4
  • 15
    • 77957807220 scopus 로고    scopus 로고
    • GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation
    • K. Oktay, I. Turkcuoglu, and K. A. Rodriguez-Wallberg, "GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation, " Reproductive BioMedicine Online, vol. 20, no. 6, pp. 783-788, 2010.
    • (2010) Reproductive BioMedicine Online , vol.20 , Issue.6 , pp. 783-788
    • Oktay, K.1    Turkcuoglu, I.2    Rodriguez-Wallberg, K.A.3
  • 16
    • 3242693780 scopus 로고    scopus 로고
    • Triggering of ovulation, using different regimen of gonadotropin-releasing hormone agonist
    • I. Parneix, J. C. Emperaire, and A. Ruffie, "Triggering of ovulation, using different regimen of gonadotropin-releasing hormone agonist, "Gynecological Endocrinology, vol. 10, supplement 1, p. 32, 1996.
    • (1996) Gynecological Endocrinology , vol.10 , pp. 32
    • Parneix, I.1    Emperaire, J.C.2    Ruffie, A.3
  • 17
    • 59349114171 scopus 로고    scopus 로고
    • Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropinreleasing hormone antagonist-treated oocyte donor cycles: Findings of a large retrospective cohort study
    • D. Bodri, J. J. Guillen, A. Galindo, D. Mataro, A. Pujol, and O. Coll, "Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropinreleasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study, " Fertility and Sterility, vol. 91, no. 2, pp. 365-371, 2009.
    • (2009) Fertility and Sterility , vol.91 , Issue.2 , pp. 365-371
    • Bodri, D.1    Guillen, J.J.2    Galindo, A.3    Mataro, D.4    Pujol, A.5    Coll, O.6
  • 18
    • 84883137526 scopus 로고    scopus 로고
    • GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: Two prospective randomized controlled multi-centre studies in IVF patients
    • P. Humaidan, N. P. Polyzos, B. Alsbjerg, et al., "GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients, " Human Reproduction, vol. 28, no. 9, pp. 2511-2521, 2013.
    • (2013) Human Reproduction , vol.28 , Issue.9 , pp. 2511-2521
    • Humaidan, P.1    Polyzos, N.P.2    Alsbjerg, B.3
  • 19
    • 38049170879 scopus 로고    scopus 로고
    • The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomized controlled study
    • L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva, "The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study, " Fertility and Sterility, vol. 89, no. 1, pp. 84-91, 2008.
    • (2008) Fertility and Sterility , vol.89 , Issue.1 , pp. 84-91
    • Engmann, L.1    Diluigi, A.2    Schmidt, D.3    Nulsen, J.4    Maier, D.5    Benadiva, C.6
  • 21
    • 33751230189 scopus 로고    scopus 로고
    • Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates
    • B. Acevedo, J. L. Gomez-Palomares, E. Ricciarelli, and E. R. Hernandez, "Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates, " Fertility and Sterility, vol. 86, no. 6, pp. 1682-1687, 2006.
    • (2006) Fertility and Sterility , vol.86 , Issue.6 , pp. 1682-1687
    • Acevedo, B.1    Gomez-Palomares, J.L.2    Ricciarelli, E.3    Hernandez, E.R.4
  • 22
    • 70449397316 scopus 로고    scopus 로고
    • GnRH agonist versus recombinant HCG in an oocyte donation programme: A randomized, prospective, controlled, assessor-blind study
    • M. Melo, C. E. Busso, J. Bellver, et al., "GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study, " Reproductive BioMedicine Online, vol. 19, no. 4, pp. 486-492, 2009.
    • (2009) Reproductive BioMedicine Online , vol.19 , Issue.4 , pp. 486-492
    • Melo, M.1    Busso, C.E.2    Bellver, J.3
  • 23
    • 70349595082 scopus 로고    scopus 로고
    • Ovulation triggering with GnRH agonist vs. HCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: A prospective randomized cross-over trial
    • A. Sismanoglu, H. I. Tekin, H. F. Erden, N. H. Ciray, U. Ulug, and M. Bahceci, "Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial, " Journal of Assisted Reproduction and Genetics, vol. 26, no. 5, pp. 251-256, 2009.
    • (2009) Journal of Assisted Reproduction and Genetics , vol.26 , Issue.5 , pp. 251-256
    • Sismanoglu, A.1    Tekin, H.I.2    Erden, H.F.3    Ciray, N.H.4    Ulug, U.5    Bahceci, M.6
  • 24
    • 84856667717 scopus 로고    scopus 로고
    • TriggeringwithGnRH agonist in oocyte-donation cycles: Oestradiol monitoring is not necessary during ovarian stimulation
    • J. C. Castillo, M. Dolz, J. Moreno, et al., "TriggeringwithGnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation, " Reproductive BioMedicine Online, vol. 24, no. 2, pp. 247-250, 2012.
    • (2012) Reproductive BioMedicine Online , vol.24 , Issue.2 , pp. 247-250
    • Castillo, J.C.1    Dolz, M.2    Moreno, J.3
  • 25
    • 20444394425 scopus 로고    scopus 로고
    • GnRH agonist (buserelin) or hCGfor ovulation induction inGnRH antagonist IVF/ICSI cycles: A prospective randomized study
    • P. Humaidan, H. E. Bredkjar, L. Bungum, et al., "GnRH agonist (buserelin) or hCGfor ovulation induction inGnRH antagonist IVF/ICSI cycles: a prospective randomized study, " Human Reproduction, vol. 20, no. 5, pp. 1213-1220, 2005.
    • (2005) Human Reproduction , vol.20 , Issue.5 , pp. 1213-1220
    • Humaidan, P.1    Bredkjar, H.E.2    Bungum, L.3
  • 26
    • 27144499019 scopus 로고    scopus 로고
    • A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists
    • E. M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, et al., "A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists, " Human Reproduction, vol. 20, no. 10, pp. 2887-2892, 2005.
    • (2005) Human Reproduction , vol.20 , Issue.10 , pp. 2887-2892
    • Kolibianakis, E.M.1    Schultze-Mosgau, A.2    Schroer, A.3
  • 27
    • 84857789622 scopus 로고    scopus 로고
    • Agonist trigger: What is the best approach? Agonist trigger with aggressive luteal support
    • L. Engmann and C. Benadiva, "Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support, " Fertility and Sterility, vol. 97, no. 3, pp. 531-533, 2012.
    • (2012) Fertility and Sterility , vol.97 , Issue.3 , pp. 531-533
    • Engmann, L.1    Benadiva, C.2
  • 28
    • 84865736553 scopus 로고    scopus 로고
    • Intensive luteal phase support after GnRH agonist trigger: It does help
    • C. Benadiva and L. Engmann, "Intensive luteal phase support after GnRH agonist trigger: it does help, " Reproductive BioMedicine Online, vol. 25, no. 3, pp. 329-330, 2012.
    • (2012) Reproductive BioMedicine Online , vol.25 , Issue.3 , pp. 329-330
    • Benadiva, C.1    Engmann, L.2
  • 29
    • 65649133617 scopus 로고    scopus 로고
    • Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: A pilot study
    • P. Humaidan, "Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study, " Reproductive BioMedicine Online, vol. 18, no. 5, pp. 630-634, 2009.
    • (2009) Reproductive BioMedicine Online , vol.18 , Issue.5 , pp. 630-634
    • Humaidan, P.1
  • 30
    • 79951945981 scopus 로고    scopus 로고
    • A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: A randomized prospective proof of concept study
    • E. G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye, "A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study, " Fertility and Sterility, vol. 95, no. 3, pp. 1174-1177, 2011.
    • (2011) Fertility and Sterility , vol.95 , Issue.3 , pp. 1174-1177
    • Papanikolaou, E.G.1    Verpoest, W.2    Fatemi, H.3    Tarlatzis, B.4    Devroey, P.5    Tournaye, H.6
  • 31
    • 33748603491 scopus 로고    scopus 로고
    • Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
    • A. Tavaniotou and P. Devroey, "Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles, " Reproductive BioMedicine Online, vol. 13, no. 3, pp. 326-330, 2006.
    • (2006) Reproductive BioMedicine Online , vol.13 , Issue.3 , pp. 326-330
    • Tavaniotou, A.1    Devroey, P.2
  • 32
    • 77952295059 scopus 로고    scopus 로고
    • The luteal phase after 3 decades of IVF: What do we know?
    • H. M. Fatemi, "The luteal phase after 3 decades of IVF: what do we know?" Reproductive Biomedicine Online, vol. 19, supplement 4, p. 4331, 2009.
    • (2009) Reproductive Biomedicine Online , vol.19 , pp. 4331
    • Fatemi, H.M.1
  • 34
    • 0018947070 scopus 로고
    • Establishing full-term human pregnancies using cleaving embryos grown in vitro
    • R. G. Edwards, P. C. Steptoe, and J. M. Purdy, "Establishing full-term human pregnancies using cleaving embryos grown in vitro, " British Journal of Obstetrics and Gynaecology, vol. 87, no. 9, pp. 737-756, 1980.
    • (1980) British Journal of Obstetrics and Gynaecology , vol.87 , Issue.9 , pp. 737-756
    • Edwards, R.G.1    Steptoe, P.C.2    Purdy, J.M.3
  • 36
    • 80052912626 scopus 로고    scopus 로고
    • GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: A proof of concept study
    • S. Kol, P. Humaidan, and J. Itskovitz-Eldor, "GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study, " Human Reproduction, vol. 26, no. 10, pp. 2874-2877, 2011.
    • (2011) Human Reproduction , vol.26 , Issue.10 , pp. 2874-2877
    • Kol, S.1    Humaidan, P.2    Itskovitz-Eldor, J.3
  • 37
    • 60749083585 scopus 로고    scopus 로고
    • Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: A randomised clinical trial
    • A. Galindo, D. Bodri, J. J. Guillen, M. Colodron, V. Vernaeve, and O. Coll, "Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial, " Gynecological Endocrinology, vol. 25, no. 1, pp. 60-66, 2009.
    • (2009) Gynecological Endocrinology , vol.25 , Issue.1 , pp. 60-66
    • Galindo, A.1    Bodri, D.2    Guillen, J.J.3    Colodron, M.4    Vernaeve, V.5    Coll, O.6
  • 38
    • 84883175768 scopus 로고    scopus 로고
    • Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG
    • A. Seyhan, B. Ata, M. Polat, W. Son, H. Yarali, and M. H. Dahan, "Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG, " Human Reproduction, vol. 28, no. 9, pp. 2522-2528, 2013.
    • (2013) Human Reproduction , vol.28 , Issue.9 , pp. 2522-2528
    • Seyhan, A.1    Ata, B.2    Polat, M.3    Son, W.4    Yarali, H.5    Dahan, M.H.6
  • 39
    • 33747059580 scopus 로고    scopus 로고
    • Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF\ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: A pilot study
    • P. Humaidan, L. Bungum, M. Bungum, and C. Y. Andersen, "Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF\ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study, " Reproductive BioMedicine Online, vol. 13, no. 2, pp. 173-178, 2006.
    • (2006) Reproductive BioMedicine Online , vol.13 , Issue.2 , pp. 173-178
    • Humaidan, P.1    Bungum, L.2    Bungum, M.3    Andersen, C.Y.4
  • 40
    • 84883197086 scopus 로고    scopus 로고
    • GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients
    • P. Humaidan, L. H. Thomsen, and B. Alsbjerg, "GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients, " Human Reproduction, vol. 28, no. 9, pp. 2593-2594, 2013.
    • (2013) Human Reproduction , vol.28 , Issue.9 , pp. 2593-2594
    • Humaidan, P.1    Thomsen, L.H.2    Alsbjerg, B.3
  • 41
    • 79954988975 scopus 로고    scopus 로고
    • Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a freeze-all" strategy: A prospective multicentric study
    • G. Griesinger, L. Schultz, T. Bauer, A. Broessner, T. Frambach, and S. Kissler, "Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study, " Fertility and Sterility, vol. 95, no. 6, pp. 2029-2033, 2011.
    • (2011) Fertility and Sterility , vol.95 , Issue.6 , pp. 2029-2033
    • Griesinger, G.1    Schultz, L.2    Bauer, T.3    Broessner, A.4    Frambach, T.5    Kissler, S.6
  • 42
    • 80052902532 scopus 로고    scopus 로고
    • An OHSS-free clinic by segmentation of IVF treatment
    • P. Devroey, N. P. Polyzos, and C. Blockeel, "An OHSS-free clinic by segmentation of IVF treatment, " Human Reproduction, vol. 26, no. 10, pp. 2593-2597, 2011.
    • (2011) Human Reproduction , vol.26 , Issue.10 , pp. 2593-2597
    • Devroey, P.1    Polyzos, N.P.2    Blockeel, C.3
  • 43
    • 84897128895 scopus 로고    scopus 로고
    • Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and freeze-all approach in GnRH antagonist protocol
    • H. Mousavi Fatemi, B. Popovic-Todorovic, P. Humaidan, et al., "Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol, " Fertility and Sterility, vol. 101, no. 4, pp. 1008-1011, 2014.
    • (2014) Fertility and Sterility , vol.101 , Issue.4 , pp. 1008-1011
    • Mousavi Fatemi, H.1    Popovic-Todorovic, B.2    Humaidan, P.3
  • 44
    • 84863213788 scopus 로고    scopus 로고
    • Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS
    • J. C. Castillo, G. Juan, and P. Humaidan, "Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS, " Journal of Assisted Reproduction and Genetics, vol. 29, no. 3, pp. 249-253, 2012.
    • (2012) Journal of Assisted Reproduction and Genetics , vol.29 , Issue.3 , pp. 249-253
    • Castillo, J.C.1    Juan, G.2    Humaidan, P.3
  • 45
    • 0142094578 scopus 로고    scopus 로고
    • Successful treatment of empty follicle syndrome by triggering endogenous LH surge using GnRH agonist in an antagonist down-regulated IVF cycle
    • F. Lok, J. Pritchard, and H. Lashen, "Successful treatment of empty follicle syndrome by triggering endogenous LH surge using GnRH agonist in an antagonist down-regulated IVF cycle, " Human Reproduction, vol. 18, no. 10, pp. 2079-2081, 2003.
    • (2003) Human Reproduction , vol.18 , Issue.10 , pp. 2079-2081
    • Lok, F.1    Pritchard, J.2    Lashen, H.3
  • 48
    • 0015218538 scopus 로고
    • Gonadotropinreleasing hormone: One polypeptide regulates secretion of luteinizing and follicle-stimulating hormones
    • A. V. Schally, A. Arimura, A. J. Kastin, et al., "Gonadotropinreleasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones, " Science, vol. 173, no. 4001, pp. 1036-1038, 1971.
    • (1971) Science , vol.173 , Issue.4001 , pp. 1036-1038
    • Schally, A.V.1    Arimura, A.2    Kastin, A.J.3
  • 49
    • 84864067222 scopus 로고    scopus 로고
    • Kisspeptins and reproduction: Physiological roles and regulatory mechanisms
    • L. Pinilla, E. Aguilar, C. Dieguez, R. P. Millar, and M. Tena-Sempere, "Kisspeptins and reproduction: physiological roles and regulatory mechanisms, " Physiological Reviews, vol. 92, no. 3, pp. 1235-1316, 2012.
    • (2012) Physiological Reviews , vol.92 , Issue.3 , pp. 1235-1316
    • Pinilla, L.1    Aguilar, E.2    Dieguez, C.3    Millar, R.P.4    Tena-Sempere, M.5
  • 50
    • 84904686661 scopus 로고    scopus 로고
    • The kisspeptins-GnRH pathway in human reproductive health and disease
    • K. Skorupskaite, J. T. George, and R. A. Anderson, "The kisspeptins-GnRH pathway in human reproductive health and disease, " Human Reproduction Update, vol. 20, no. 4, pp. 485-500, 2014.
    • (2014) Human Reproduction Update , vol.20 , Issue.4 , pp. 485-500
    • Skorupskaite, K.1    George, J.T.2    Anderson, R.A.3
  • 51
    • 83155177121 scopus 로고    scopus 로고
    • The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans
    • C. N. Jayasena, G. M. K. Nijher, A. N. Comninos, et al., "The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans, " Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 12, pp. E1963-E1972, 2011.
    • (2011) Journal of Clinical Endocrinology and Metabolism , vol.96 , Issue.12 , pp. E1963-E1972
    • Jayasena, C.N.1    Nijher, G.M.K.2    Comninos, A.N.3
  • 52
    • 84887417775 scopus 로고    scopus 로고
    • Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteers
    • C. N. Jayasena, A. Comninos, G. Nijher, et al., "Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteers, "The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 11, pp. 4464-4474, 2013.
    • (2013) The Journal of Clinical Endocrinology and Metabolism , vol.98 , Issue.11 , pp. 4464-4474
    • Jayasena, C.N.1    Comninos, A.2    Nijher, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.